XENE icon

Xenon Pharmaceuticals
XENE

Overview Fund Activity

80 hedge funds and large institutions have $308M invested in Xenon Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 27 reducing their positions, and 5 closing their positions.

Holders
80
Holders Change
+1
Holders Change %
+1.27%
% of All Funds
1.62%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
16
Reduced
27
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$29.1M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$27.1M
3
SCM
3
Soleus Capital Management
Connecticut
$5.54M
4
GIM
4
Granahan Investment Management
Massachusetts
$1.76M
5
Goldman Sachs
5
Goldman Sachs
New York
$686K

Top Sellers

1
ACP
1
Acuta Capital Partners
California
$3.32M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$4.95M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$10M
4
PHP
4
Parkman Healthcare Partners
Connecticut
$5.15M
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BI
1
BVF Inc
California
$38.7M 3,499,346 -17,505 -0.5%
ACA
2
Avoro Capital Advisors
New York
$31M 2,800,000 – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$29.1M 2,624,620 +425,566 +19%
O
4
OrbiMed
New York
$27.7M 2,497,917 – –
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$27.1M 2,450,000 +425,000 +21%
EAM
6
Eventide Asset Management
Massachusetts
$14.1M 1,274,100 – –
Capital International Investors
7
Capital International Investors
California
$11.7M 1,055,726 – –
NMC
8
NEA Management Company
Maryland
$11M 992,107 – –
Capital World Investors
9
Capital World Investors
California
$10.7M 963,500 – –
Renaissance Technologies
10
Renaissance Technologies
New York
$10M 903,277 -132,000 -13%
BBA
11
Baker Bros. Advisors
New York
$8.42M 760,308 -38,794 -5%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$8.27M 746,803 -47,886 -6%
BC
13
Boxer Capital
California
$6.64M 600,000 – –
RSCM
14
Rock Springs Capital Management
Maryland
$5.71M 515,711 – –
SCM
15
Soleus Capital Management
Connecticut
$5.54M 500,264 +249,367 +99%
PHP
16
Parkman Healthcare Partners
Connecticut
$5.15M 464,825 -125,442 -21%
DCM
17
Driehaus Capital Management
Illinois
$5M 451,307 -12,926 -3%
Point72 Asset Management
18
Point72 Asset Management
Connecticut
$4.95M 447,061 -212,343 -32%
UBS AM
19
UBS AM
Illinois
$4.08M 368,279 +3,522 +1%
DCM
20
DAFNA Capital Management
California
$3.84M 346,535 – –
GTC
21
Ghost Tree Capital
New York
$3.6M 325,000 – –
Citadel Advisors
22
Citadel Advisors
Florida
$3.45M 311,682 -78,578 -20%
ACP
23
Acuta Capital Partners
California
$3.32M 300,000 -217,500 -42%
IC
24
Ikarian Capital
Texas
$2.47M 223,173 -75,000 -25%
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$2.13M 192,313 -17,305 -8%
1
2 3 4